94.83
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $94.83, with a volume of 4.54M.
It is up +2.47% in the last 24 hours and up +12.09% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$92.54
Open:
$92.16
24h Volume:
4.54M
Relative Volume:
1.30
Market Cap:
$61.02B
Revenue:
$77.59B
Net Income/Loss:
$3.62B
P/E Ratio:
18.34
EPS:
5.1701
Net Cash Flow:
$16.53B
1W Performance:
+0.88%
1M Performance:
+12.09%
6M Performance:
+25.09%
1Y Performance:
+21.91%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PRU, PUK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
94.83 | 61.02B | 77.59B | 3.62B | 16.53B | 5.1701 |
|
MFC
Manulife Financial Corp
|
43.67 | 72.58B | 44.31B | 4.69B | 20.94B | 2.5185 |
|
AFL
Aflac Inc
|
125.60 | 63.93B | 18.11B | 4.64B | 2.93B | 8.812 |
|
PRU
Prudential Financial Inc
|
119.96 | 41.67B | 62.83B | 3.60B | 9.79B | 9.7297 |
|
PUK
Prudential Plc Adr
|
29.34 | 36.52B | 27.81B | 4.12B | 1.87B | 3.07 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
MetLife, Inc. Depositary Shares Revenue Breakdown – NYSE:MET/PE - TradingView
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
MetLife Inc (MET) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MetLife Inc (MET) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MET|MetLife Inc|Price:92.540| - TradingKey
MetLife stock trades steadily as earnings and dividend support valuation - AD HOC NEWS
MetLife stock trades steadily as higher premiums and investment income support earnings - AD HOC NEWS
MET5615830 Bond Profile — Key Metrics - TradingView
NJ assemblyman says FIFA’s MetLife grass sale is ‘Illegal,’ moves to block it - Yahoo
Westpac Banking Corp Buys 14,116 Shares of MetLife, Inc. $MET - MarketBeat
MET6026989 Bond Profile — Key Metrics - TradingView
MetLife stock holds steady as results and capital levels frame the outlook - AD HOC NEWS
Danica Pension Livsforsikringsaktieselskab Invests $8.26 Million in MetLife, Inc. $MET - MarketBeat
ABN Amro Investment Solutions Has $10.99 Million Position in MetLife, Inc. $MET - MarketBeat
MET|MetLife Inc|Price:92.550|Chg%:-0.720 - TradingKey
Why Is MetLife (NYSE:MET) Mixed Use Project Gaining S&P 500? - Kalkine Media
US59156RCQ9 Bond Profile — Key Metrics - TradingView
MetLife Investment Management Celebrates Grand Opening of Emerald at MetWest, Completing Mixed-Use Vision for MetWest International - Business Wire
TD Cowen Adjusts MetLife Price Target to $105 From $87, Maintains Buy Rating - marketscreener.com
MET3887852 Bond Profile — Key Metrics - TradingView
Analyst recommendations: Amcor, Coreweave, JPMorgan Chase, AMD, MetLife… - marketscreener.com
METLIFE INC : TD COWEN RAISES TARGET PRICE TO $105 FROM $87 - Moomoo
ETFs Investing in MetLife, Inc. Floating Rate Non Cum Pfd Registered Shs Series -A- Stocks - TradingView
MetLife 2025 Sustainability Report: Responsible Investments - Morningstar
JPMorgan Chase & Co. Raises MetLife (NYSE:MET) Price Target to $106.00 - MarketBeat
MetLife stock trades steadily as earnings and capital return frame the outlook - Ad-hoc-news.de
MetLife: Supply to drive multifamily market performance through 2028 - Institutional Real Estate, Inc.
JPMorgan Adjusts Price Target on MetLife to $106 From $96, Maintains Overweight Rating - marketscreener.com
Swiss National Bank Has $116.23 Million Position in MetLife, Inc. $MET - MarketBeat
Dimensional Fund Advisors LP Has $503.64 Million Stock Holdings in MetLife, Inc. $MET - MarketBeat
MWZD Bond Profile — Key Metrics - TradingView
MetLife Inc. stock underperforms Monday when compared to competitors - MarketWatch
Lobbying Update: $370,000 of METLIFE GROUP INC. lobbying was just disclosed - Quiver Quantitative
What to expect from MetLife's next quarterly earnings report - MSN
What to Expect From MetLife's Next Quarterly Earnings Report - Barchart.com
Mediolanum International Funds Ltd Lowers Holdings in MetLife, Inc. $MET - MarketBeat
KBC Group NV Sells 65,545 Shares of MetLife, Inc. $MET - MarketBeat
MetLife, Inc. $MET Position Trimmed by Wealthfront Advisers LLC - MarketBeat
MetLife, Inc. $MET Shares Sold by Boston Common Asset Management LLC - MarketBeat
California Public Employees Retirement System Purchases 24,552 Shares of MetLife, Inc. $MET - MarketBeat
MetLife stock trades steady as earnings and dividend frame valuation - AD HOC NEWS
SEB Asset Management AB Takes $45.03 Million Position in MetLife, Inc. $MET - MarketBeat
Valley Wealth Managers Inc. Increases Position in MetLife, Inc. $MET - MarketBeat
Jennison Associates LLC Has $183.62 Million Position in MetLife, Inc. $MET - MarketBeat
ETFs Investing in MetLife, Inc. Depositary Shs Repr 1/1000th 4.75 % Non-Cum Perp Red Pfd Shs Series F Stocks - TradingView
AIA Group Ltd Acquires 114,997 Shares of MetLife, Inc. $MET - MarketBeat
MetLife stock trades steadily as earnings and capital return shape 2026 outlook - ad-hoc-news.de
MET.GL Bond Profile — Key Metrics - TradingView
MET4218548 Bond Profile — Key Metrics - TradingView
MET.GL Bond Risk Profile - TradingView
MetLife stock trades near yearly high as earnings and buybacks support valuation - AD HOC NEWS
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):